News
ANGO reports solid fiscal third-quarter earnings with continued strength in its Med Tech segment. The expansion of gross margin bodes well. AngioDynamics Inc (ANGO) reports a robust 9% revenue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback